Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Prospective genome sequencing of multidrug-resistant bacterial pathogens

PROVIDER: PRJEB8084 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1195490_1.fastq.gz	Fastqsanger.gz
	ERR1195490_2.fastq.gz	Fastqsanger.gz
	ERR1195520_1.fastq.gz	Fastqsanger.gz
	ERR1195520_2.fastq.gz	Fastqsanger.gz
	ERR1195530_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1850

Similar Datasets

Project description:Genomic Surveillance of Multidrug-Resistant Bacterial Pathogens in Vietnam

| PRJNA1443008 | ENA

Characterization of broad-host-range bacteriophages targeting multidrug- resistant E. coli and Shigella spp.: in vitro Potential

Project description:bacteriophages targeting multidrug- resistant pathogens

| PRJEB85437 | ENA

Multidrug-resistant bacterial species from clinical surveillance in Mexico

Project description:Genomic surveillance of emerging multidrug-resistant bacterial pathogens in Mexico

| PRJNA1295662 | ENA

The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model

Project description:Objectives: Colistin remains a last-line treatment for multidrug-resistant Acinetobacter baumannii and combined use of colistin and carbapenems has shown synergistic effects against multidrug-resistant strains. In order to understand the bacterial responses to these antibiotics we analysed the transcriptome of A. baumannii following exposure to each.

2014-11-30 | GSE62794 | GEO

Enhanced Proteolytic Stability and Distinct Mechanisms of a D-Amino Acid-Modified Antimicrobial Peptide Against Pseudomonas aeruginosa

Project description:Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics for the treatment of multidrug-resistant (MDR) pathogens; however, their clinical translation is limited by proteolytic degradation.

2026-03-22 | PXD075939 | JPOST Repository

Glutamate-mediated metabolic rewiring boosts CpxA/R-OmpF porin and proton motive force to resensitize antibiotic-resistant Escherichia coli to ceftazidime

Project description:Ceftazidime (CAZ) is a critically important broad-spectrum antibiotic widely used in clinical practice. However, the rapid emergence of bacterial resistance to CAZ poses a significant challenge in treating infections caused by multidrug-resistant pathogens. In this study, we employed a metabolism-reprogramming approach to characterize key features of laboratory-evolved CAZ-resistant Escherichia coli K12 and identified repressed glutamate metabolism as a reprogrammable target. Exogenous glutamate effectively resensitized both lab-evolved and clinically isolated multidrug-resistant E. coli strains to CAZ. The resensitization mechanism operates through two synergistic pathways driven by glutamate metabolic flux. First, glutamate conversion to inosine activates the inosine–CpxA–CpxR–OmpF regulatory axis, increasing outer membrane permeability. Second, glutamate entry into the pyruvate cycle restores the proton motive force (PMF), energizing the inner membrane. Together, increased outer membrane permeability and a restored PMF synergistically enhance intracellular accumulation of CAZ—by facilitating its entry through the widened OmpF porin and promoting its active uptake across the cytoplasmic membrane. This dual-mechanism strategy provides a novel two-pronged approach to overcoming CAZ resistance. Our findings underscore the potential of targeting bacterial metabolic pathways to restore susceptibility and extend the utility of existing antibiotics against resistant pathogens.Keywords: Multidrug-resistant bacteria; E. coli; glutamate; CpxA/R-OmpF axis; proton motive force; metabolic state-reprogramming

2026-01-20 | MTBLS13732 | MetaboLights

Renz2021 - Collection of 64 SBML L3V1 genome-scale metabolic models (FBC Version 2) of Staphylococcus aureus

Project description:Staphylococcus aureus is a high-priority pathogen causing severe infections with high morbidity and mortality worldwide. Many S. aureus strains are methicillin-resistant (MRSA) or even multi-drug resistant. It is one of the most successful and prominent modern pathogens. An effective fight against S. aureus infections requires novel targets for antimicrobial and antistaphylococcal therapies. Recent advances in whole-genome sequencing and high-throughput techniques facilitate the generation of genome-scale metabolic models (GEMs). Among the multiple applications of GEMs is drug-targeting in pathogens. Hence, comprehensive and predictive metabolic reconstructions of S. aureus could facilitate the identification of novel targets for antimicrobial therapies. This review aims at giving an overview of all available GEMs of multiple S. aureus strains. We downloaded all 114 available GEMs of S. aureus for further analysis. The scope of each model was evaluated, including the number of reactions, metabolites, and genes.Furthermore, all models were quality-controlled using Mᴇᴍᴏᴛᴇ, an open-source application with standardized metabolic tests. Growth capabilities and model similarities were examined. This review should lead as a guide for choosing the appropriate GEM for a given research question. With the information about the availability, the format, and the strengths and potentials of each model, one can either choose an existing model or combine several models to create models with even higher predictive values. This facilitates model-driven discoveries of novel antimicrobial targets to fight multi-drug resistant S. aureus strains.

2022-02-16 | MODEL2007110001 | BioModels

Renz2021 - Collection of 13 SBML L3V1 constraint-based models (FBC Version 2) of Staphylococcus aureus

Project description:Staphylococcus aureus is a high-priority pathogen causing severe infections with high morbidity and mortality worldwide. Many S. aureus strains are methicillin-resistant (MRSA) or even multi-drug resistant. It is one of the most successful and prominent modern pathogens. An effective fight against S. aureus infections requires novel targets for antimicrobial and antistaphylococcal therapies. Recent advances in whole-genome sequencing and high-throughput techniques facilitate the generation of genome-scale metabolic models (GEMs). Among the multiple applications of GEMs is drug-targeting in pathogens. Hence, comprehensive and predictive metabolic reconstructions of S. aureus could facilitate the identification of novel targets for antimicrobial therapies. This review aims at giving an overview of all available GEMs of multiple S. aureus strains. We downloaded all 114 available GEMs of S. aureus for further analysis. The scope of each model was evaluated, including the number of reactions, metabolites, and genes. Furthermore, all models were quality-controlled using Mᴇᴍᴏᴛᴇ, an open-source application with standardized metabolic tests. Growth capabilities and model similarities were examined. This review should lead as a guide for choosing the appropriate GEM for a given research question. With the information about the availability, the format, and the strengths and potentials of each model, one can either choose an existing model or combine several models to create models with even higher predictive values. This facilitates model-driven discoveries of novel antimicrobial targets to fight multi-drug resistant S. aureus strains.

2022-02-16 | MODEL2007150001 | BioModels

Renz2021 - Collection of 33 SBML L3V1 (FBC Version 2) models of Staphylococcus aureus by the Path2Models project 2013

2022-02-16 | MODEL2007150002 | BioModels

Project description:Multidrug-resistant pathogens in the food chain

| PRJNA662907 | ENA